- Home
- BMRN vs GNRC Comparison
BMRN vs GNRC Comparison
Compare BMRN & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- GNRC
- Stock Information
- Founded
- BMRN 1996
- GNRC 1959
- Country
- BMRN United States
- GNRC United States
- Employees
- BMRN N/A
- GNRC N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- GNRC Metal Fabrications
- Sector
- BMRN Health Care
- GNRC Consumer Discretionary
- Exchange
- BMRN Nasdaq
- GNRC Nasdaq
- Market Cap
- BMRN 11.1B
- GNRC 10.8B
- IPO Year
- BMRN 1999
- GNRC 2010
- Fundamental
- Price
- BMRN $54.65
- GNRC $166.69
- Analyst Decision
- BMRN Buy
- GNRC Buy
- Analyst Count
- BMRN 20
- GNRC 18
- Target Price
- BMRN $92.21
- GNRC $184.00
- AVG Volume (30 Days)
- BMRN 2.2M
- GNRC 990.3K
- Earning Date
- BMRN 10-28-2025
- GNRC 10-30-2025
- Dividend Yield
- BMRN N/A
- GNRC N/A
- EPS Growth
- BMRN 154.69
- GNRC 54.62
- EPS
- BMRN 3.40
- GNRC 6.03
- Revenue
- BMRN $3,063,608,000.00
- GNRC $4,411,654,000.00
- Revenue This Year
- BMRN $13.35
- GNRC $5.38
- Revenue Next Year
- BMRN $9.18
- GNRC $8.33
- P/E Ratio
- BMRN $16.09
- GNRC $27.68
- Revenue Growth
- BMRN 18.36
- GNRC 9.69
- 52 Week Low
- BMRN $52.48
- GNRC $99.50
- 52 Week High
- BMRN $73.51
- GNRC $203.25
- Technical
- Relative Strength Index (RSI)
- BMRN 47.87
- GNRC 41.04
- Support Level
- BMRN $53.19
- GNRC $162.59
- Resistance Level
- BMRN $54.50
- GNRC $170.52
- Average True Range (ATR)
- BMRN 1.20
- GNRC 5.62
- MACD
- BMRN 0.29
- GNRC -0.84
- Stochastic Oscillator
- BMRN 62.43
- GNRC 19.19
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.